Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Dec 19, 2024

SELL
$272.21 - $332.43 $1,088 - $1,329
-4 Closed
0 $0
Q2 2021

Dec 19, 2024

BUY
$225.08 - $271.69 $900 - $1,086
4 New
4 $1.07 Million
Q4 2019

Dec 19, 2024

SELL
$133.47 - $153.48 $41,375 - $47,578
-310 Closed
0 $0
Q1 2019

Dec 19, 2024

SELL
$97.62 - $132.29 $8,004 - $10,847
-82 Reduced 20.92%
310 $40.9 Million
Q1 2018

Dec 19, 2024

SELL
$92.16 - $103.8 $5,529 - $6,228
-60 Reduced 13.27%
392 $38.4 Million
Q4 2017

Dec 19, 2024

BUY
$85.26 - $94.62 $38,537 - $42,768
452
452 $42 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $165B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Arcadia Investment Advisors LLC Portfolio

Follow Arcadia Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcadia Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arcadia Investment Advisors LLC with notifications on news.